Protalix BioTherapeutics (PLX) FCF Margin Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 5,389.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,525.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -341.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 43,511.00 |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | 11,865.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11,865.00 |
| Dec 31, 2025 | 653.00 |
| Sep 30, 2025 | -4,246.00 |
| Jun 30, 2025 | -1,215.00 |
| Mar 31, 2025 | -15,002.00 |
| Dec 31, 2024 | -562.00 |
| Sep 30, 2024 | 8,342.00 |
| Jun 30, 2024 | -3,685.00 |
| Mar 31, 2024 | 12,964.00 |
| Dec 31, 2023 | 6,042.00 |
| Sep 30, 2023 | 111.00 |
| Jun 30, 2023 | 9,595.00 |
| Mar 31, 2023 | 381.00 |
| Dec 31, 2022 | 3,516.00 |
| Sep 30, 2022 | -4,732.00 |
| Jun 30, 2022 | -17,936.00 |
| Mar 31, 2022 | 5,262.00 |
| Dec 31, 2021 | -2,634.00 |
| Sep 30, 2021 | 1,590.00 |
| Jun 30, 2021 | 17,039.00 |
| Mar 31, 2021 | -5,710.00 |
| Dec 31, 2020 | -1,561.00 |
| Sep 30, 2020 | -896.00 |
| Jun 30, 2020 | -3,086.00 |
| Mar 31, 2020 | 3,814.00 |
| Dec 31, 2019 | 18,968.00 |
| Sep 30, 2019 | -206,686.00 |
| Jun 30, 2019 | 36,172.00 |
| Mar 31, 2019 | 14,088.00 |
| Dec 31, 2018 | -118,003.00 |
| Sep 30, 2018 | 218,489.00 |
| Jun 30, 2018 | -26,551.00 |
| Mar 31, 2018 | 32,047.00 |
| Dec 31, 2017 | 132,633.00 |
| Sep 30, 2017 | -6,656.00 |
| Jun 30, 2017 | 56,071.00 |
| Mar 31, 2017 | 86,923.00 |
| Sep 30, 2016 | 67,420.00 |
| Jun 30, 2016 | -35,610.00 |
| Mar 31, 2016 | -103,158.00 |
| Mar 31, 2015 | -24,185.00 |
| Mar 31, 2014 | 15,818.00 |
| Dec 31, 2013 | -15,481.00 |
| Sep 30, 2013 | -13,776.00 |
| Jun 30, 2013 | -43,840.00 |
| Mar 31, 2013 | -10,300.00 |
| Dec 31, 2012 | 44,370.00 |
| Sep 30, 2012 | 57,044.00 |
| Jun 30, 2012 | 86,545.00 |
| Mar 31, 2012 | -2,397.00 |
| Dec 31, 2011 | 46,152.00 |
| Sep 30, 2011 | -46,051.00 |